Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firas Hamdan

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Materials Today. Bio|April 2, 2026
Corrigendum to 'Design and <i>in vitro</i> validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio <b>36</b>, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693]Khalil Elbadri, Manlio Fusciello, Firas Hamdan, et al.
Molecular Therapy. Oncology|April 10, 2024
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapySalvatore Russo, Sara Feola, Michaela Feodoroff, et al.
Journal of Cosmetic Dermatology|February 6, 2024
Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendationsAndrei Metelitsa, Kaitlyn M Enright, Frank Rosengaus, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptorsSara Feola, Firas Hamdan, Salvatore Russo, et al.
Frontiers in Immunology|May 2, 2022
Peptides-Coated Oncolytic Vaccines for Cancer Personalized MedicineSara Feola, Salvatore Russo, Beatriz Martins, et al.
Mabs|August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignanciesMitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Journal of Clinical Immunology|October 19, 2022
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated SignalingElina A Tuovinen, Sakari Pöysti, Firas Hamdan, et al.
Cancer Research|February 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapySiri Tähtinen, Sara Feola, Cristian Capasso, et al.
Elife|March 22, 2022
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Aesthetic Surgery Journal|July 29, 2025
Rates of Positive Aspiration Prior to Facial Hyaluronic Acid Filler Injections: Outcomes of a Multicenter, Cross-Sectional StudyAndreas Nikolis, Andrei Metelitsa, Luiz Avelar, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Materials Today. Bio|April 2, 2026
Corrigendum to 'Design and <i>in vitro</i> validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio <b>36</b>, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693]Khalil Elbadri, Manlio Fusciello, Firas Hamdan, et al.
Molecular Therapy. Oncology|April 10, 2024
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapySalvatore Russo, Sara Feola, Michaela Feodoroff, et al.
Journal of Cosmetic Dermatology|February 6, 2024
Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendationsAndrei Metelitsa, Kaitlyn M Enright, Frank Rosengaus, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptorsSara Feola, Firas Hamdan, Salvatore Russo, et al.
Frontiers in Immunology|May 2, 2022
Peptides-Coated Oncolytic Vaccines for Cancer Personalized MedicineSara Feola, Salvatore Russo, Beatriz Martins, et al.
Mabs|August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignanciesMitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Journal of Clinical Immunology|October 19, 2022
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated SignalingElina A Tuovinen, Sakari Pöysti, Firas Hamdan, et al.
Cancer Research|February 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapySiri Tähtinen, Sara Feola, Cristian Capasso, et al.
Elife|March 22, 2022
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Aesthetic Surgery Journal|July 29, 2025
Rates of Positive Aspiration Prior to Facial Hyaluronic Acid Filler Injections: Outcomes of a Multicenter, Cross-Sectional StudyAndreas Nikolis, Andrei Metelitsa, Luiz Avelar, et al.
Pageof 4